Process for the manufacture of moldings

Details for Australian Patent Application No. 2002249262 (hide)

Owner Novartis AG

Inventors Bothe, Harald; Muller, Achim; Seiferling, Bernhard

Agent Davies Collison Cave

Pub. Number AU-B-2002249262

PCT Pub. Number WO2002/071106

Priority 01105708.0 07.03.01 EP

Filing date 6 March 2002

Wipo publication date 19 September 2002

Acceptance publication date 27 January 2005

International Classifications

G02B 001/04 Optical elements characterised by the material of which they are made - made of organic materials, e.g. plastics

C08L 029/04 Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal, or ketal radical

Event Publications

13 March 2003 Application Open to Public Inspection

  Published as AU-B-2002249262

27 January 2005 Application Accepted

  Published as AU-B-2002249262

26 May 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002249263

2002249261-USE OF SPECIFIC COMPOUNDS, PARTICULARLY KINASE INHIBITORS, FOR TREATING VIRAL INFECTIONS